Why it was recalled
Label Mix - up; a bottle labeled as Atenolol 25mg Tablets contained Clopidogrel 75mg Tablets
Product description
Atenolol Tablets, USP, 25 mg, 1000-count bottle, Rx only, Manufactured by: ALPHAPHARM PTY LTD, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC 60429-027-10
Lot numbers, UPCs & expiration codes
Lot #: GS046745, Exp 12/2023
Where it was sold
USA Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0019-2023
- Classification
- Class I
- Status
- Terminated
- Recall initiated
- Sep 29, 2022
- FDA report date
- Nov 2, 2022
- Quantity
- 2,584 Bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Golden State Medical Supply Inc.
Original FDA data
Every field from FDA enforcement report D-0019-2023, exactly as published.
Show all FDA fields
- City
- Camarillo
- State
- CA
- Status
- Terminated
- Country
- United States
- Event ID
- 90909
- Address
- 5187 Camino Ruiz
- Code information
- Lot #: GS046745, Exp 12/2023
- Postal code
- 93012-8601
- Report date
- Nov 2, 2022
- Product type
- Drugs
- Recall number
- D-0019-2023
- Classification
- Class I
- Recalling firm
- Golden State Medical Supply Inc.
- Product quantity
- 2,584 Bottles
- Termination date
- Mar 20, 2025
- Reason for recall
- Label Mix - up; a bottle labeled as Atenolol 25mg Tablets contained Clopidogrel 75mg Tablets
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Atenolol Tablets, USP, 25 mg, 1000-count bottle, Rx only, Manufactured by: ALPHAPHARM PTY LTD, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC 60429-027-10
- Distribution pattern
- USA Nationwide
- Recall initiation date
- Sep 29, 2022
- Initial firm notification
- Letter
- Center classification date
- Oct 21, 2022